Trivant Custom Portfolio Group, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Trivant Custom Portfolio Group, LLC
- $163 Billion
- Q2 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 200 shares of AMPH stock, worth $9,670. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$9,670
Previous $8.78 Million
8.9%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$287 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$129 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$94 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$81.8 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$78.5 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.37B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...